.Even with izokibep keeping its newly found winning streak in the facility, Acelyrin is no longer co...
.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing medi...
.Ovid Therapeutics presently showed final month that it was actually trimming its own headcount as t...
.Eli Lilly has opened a $700 thousand R&D facility in the Boston Port, boosting its RNA and DNA r...
.Merely five months after protecting a $100 million IPO, Boundless Biography is actually presently g...
.The preliminary stages of oncology R&D may not be short of interesting new modalities, and Halda...
.Psychopharmacology has pulled 3 posts about midstage scientific trial information examining Lykos R...
.Avidity Biosciences pleased clients with phase 1/2 data in Duchenne muscle dystrophy (DMD) Friday, ...
.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a stage 2 research in c...
.Antibody-drug conjugates (ADCs) have gone to the center of lots of a billion-dollar biobuck licensi...